These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 28729033)

  • 1. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
    Harambat J; Kunzmann K; Azukaitis K; Bayazit AK; Canpolat N; Doyon A; Duzova A; Niemirska A; Sözeri B; Thurn-Valsassina D; Anarat A; Bessenay L; Candan C; Peco-Antic A; Yilmaz A; Tschumi S; Testa S; Jankauskiene A; Erdogan H; Rosales A; Alpay H; Lugani F; Arbeiter K; Mencarelli F; Kiyak A; Dönmez O; Drozdz D; Melk A; Querfeld U; Schaefer F;
    Kidney Int; 2017 Dec; 92(6):1507-1514. PubMed ID: 28729033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Serum Bicarbonate and CKD Progression in Children.
    Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML
    Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
    Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
    BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Pan Q; Appel L; Bellovich K; Chen J; Feldman H; Fischer MJ; Ham LL; Hostetter T; Jaar BG; Kallem RR; Rosas SE; Scialla JJ; Wolf M; Rahman M;
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25896890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH
    Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.
    Maruta Y; Hasegawa T; Yamakoshi E; Nishiwaki H; Koiwa F; Imai E; Hishida A
    Clin Exp Nephrol; 2019 Feb; 23(2):215-222. PubMed ID: 30168046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum bicarbonate concentrations and kidney disease progression in community-living elders: the Health, Aging, and Body Composition (Health ABC) Study.
    Goldenstein L; Driver TH; Fried LF; Rifkin DE; Patel KV; Yenchek RH; Harris TB; Kritchevsky SB; Newman AB; Sarnak MJ; Shlipak MG; Ix JH;
    Am J Kidney Dis; 2014 Oct; 64(4):542-9. PubMed ID: 24953890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
    Mathur VS; Bushinsky DA; Inker L; Klaerner G; Li E; Parsell D; Perkovic V; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Tangri N
    Nephrol Dial Transplant; 2023 May; 38(6):1448-1458. PubMed ID: 36331426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
    Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients.
    Kanda E; Ai M; Yoshida M; Kuriyama R; Shiigai T
    BMC Nephrol; 2013 Jan; 14():4. PubMed ID: 23298330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease.
    Raphael KL; Zhang Y; Ying J; Greene T
    Nephrology (Carlton); 2014 Oct; 19(10):648-54. PubMed ID: 25066359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Wesson DE; Mathur V; Tangri N; Stasiv Y; Parsell D; Li E; Klaerner G; Bushinsky DA
    Lancet; 2019 Apr; 393(10179):1417-1427. PubMed ID: 30857647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic acidosis in kidney transplant recipients.
    Skiba K; Gojowy D; Szotowska M; Bartmańska M; Kolonko A; Cierpka L; Więcek A; Adamczak M
    Pol Arch Intern Med; 2018 Oct; 128(10):587-593. PubMed ID: 30207550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of metabolic acidosis improves insulin resistance in chronic kidney disease.
    Bellasi A; Di Micco L; Santoro D; Marzocco S; De Simone E; Cozzolino M; Di Lullo L; Guastaferro P; Di Iorio B;
    BMC Nephrol; 2016 Oct; 17(1):158. PubMed ID: 27770799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Acidosis of CKD: An Update.
    Kraut JA; Madias NE
    Am J Kidney Dis; 2016 Feb; 67(2):307-17. PubMed ID: 26477665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
    Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic acidosis is associated with pulse wave velocity in chronic kidney disease: Results from the KNOW-CKD Study.
    Kim HJ; Kang E; Ryu H; Han M; Lee KB; Kim YS; Sung S; Ahn C; Oh KH
    Sci Rep; 2019 Nov; 9(1):16139. PubMed ID: 31695082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.